These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis. Thomas GA; Rhodes J; Ragunath K; Mani V; Williams GT; Newcombe RG; Russell MA; Feyerabend C Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):769-76. PubMed ID: 8864674 [TBL] [Abstract][Full Text] [Related]
24. Double blind trial of oral fluticasone propionate v prednisolone in the treatment of active ulcerative colitis. Hawthorne AB; Record CO; Holdsworth CD; Giaffer MH; Burke DA; Keech ML; Hawkey CJ Gut; 1993 Jan; 34(1):125-8. PubMed ID: 8432442 [TBL] [Abstract][Full Text] [Related]
25. Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan-prednisolone conjugate microspheres in rats with TNBS-induced colitis. Oosegi T; Onishi H; Machida Y Int J Pharm; 2008 Feb; 348(1-2):80-8. PubMed ID: 17714892 [TBL] [Abstract][Full Text] [Related]
26. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract. Liu F; Moreno P; Basit AW Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177 [TBL] [Abstract][Full Text] [Related]
27. Comparison of the efficacy and safety of Eudragit-L-coated mesalazine tablets with ethylcellulose-coated mesalazine tablets in patients with mild to moderately active ulcerative colitis. Gibson PR; Fixa B; Pekárková B; Bátovský M; Radford-Smith G; Tibitanzl J; Gabalec L; Florin TH; Greinwald R Aliment Pharmacol Ther; 2006 Apr; 23(7):1017-26. PubMed ID: 16573804 [TBL] [Abstract][Full Text] [Related]
28. Mucoadhesive platforms for targeted delivery to the colon. Varum FJ; Veiga F; Sousa JS; Basit AW Int J Pharm; 2011 Nov; 420(1):11-9. PubMed ID: 21856393 [TBL] [Abstract][Full Text] [Related]
29. Coated oral 5-aminosalicylic acid (Claversal) is equivalent to sulfasalazine for remission maintenance in ulcerative colitis. A double-blind study. Ardizzone S; Petrillo M; Molteni P; Desideri S; Bianchi Porro G J Clin Gastroenterol; 1995 Dec; 21(4):287-9. PubMed ID: 8583101 [TBL] [Abstract][Full Text] [Related]
30. Eudragit S100 coated microsponges for Colon targeting of prednisolone. Kumari A; Jain A; Hurkat P; Tiwari A; Jain SK Drug Dev Ind Pharm; 2018 Jun; 44(6):902-913. PubMed ID: 29260916 [TBL] [Abstract][Full Text] [Related]
31. Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis. Löfberg R; Danielsson A; Suhr O; Nilsson A; Schiöler R; Nyberg A; Hultcrantz R; Kollberg B; Gillberg R; Willén R; Persson T; Salde L Gastroenterology; 1996 Jun; 110(6):1713-8. PubMed ID: 8964395 [TBL] [Abstract][Full Text] [Related]
32. Investigation of the colon-targeting, improvement on the side-effects and therapy on the experimental colitis in mouse of a resin microcapsule loading dexamethasone sodium phosphate. Zeng A; Dong K; Wang M; Sun J; Dong Y; Wang K; Guo C; Yan Y; Zhang L; Shi X; Xing J Drug Deliv; 2016 Jul; 23(6):1992-2002. PubMed ID: 26006768 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and toxicity of Eudragit-coated chitosan-succinyl-prednisolone conjugate microspheres using rats with 2,4,6-trinitrobenzenesulfonic acid-induced colitis. Onishi H; Oosegi T; Machida Y Int J Pharm; 2008 Jun; 358(1-2):296-302. PubMed ID: 18394832 [TBL] [Abstract][Full Text] [Related]
34. [Study on the colon specific delivery of prednisolone using chitosan capsules]. Yamamoto A Yakugaku Zasshi; 2007 Apr; 127(4):621-30. PubMed ID: 17409691 [TBL] [Abstract][Full Text] [Related]
35. A controlled trial of alternate day prednisolone as a maintenance treatment for ulcerative colitis in remission. Powell-Tuck J; Bown RL; Chambers TJ; Lennard-Jones JE Digestion; 1981; 22(5):263-70. PubMed ID: 7030837 [TBL] [Abstract][Full Text] [Related]
36. Effect of polymer coating on faecal recovery of ingested 5-amino salicylic acid in patients with ulcerative colitis. Mardini HA; Lindsay DC; Deighton CM; Record CO Gut; 1987 Sep; 28(9):1084-9. PubMed ID: 3678967 [TBL] [Abstract][Full Text] [Related]
37. Fabrication and in vivo evaluation of highly pH-responsive acrylic microparticles for targeted gastrointestinal delivery. Kendall RA; Alhnan MA; Nilkumhang S; Murdan S; Basit AW Eur J Pharm Sci; 2009 Jun; 37(3-4):284-90. PubMed ID: 19491017 [TBL] [Abstract][Full Text] [Related]
38. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. Rachmilewitz D BMJ; 1989 Jan; 298(6666):82-6. PubMed ID: 2563951 [TBL] [Abstract][Full Text] [Related]
39. Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis - a pooled analysis. Leifeld L; Pfützer R; Morgenstern J; Gibson PR; Marakhouski Y; Greinwald R; Mueller R; Kruis W Aliment Pharmacol Ther; 2011 Nov; 34(9):1115-22. PubMed ID: 21923715 [TBL] [Abstract][Full Text] [Related]